Progress in Biomaterials

Papers
(The TQCC of Progress in Biomaterials is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Fabrication and characterization of super-hydrophilic poly (ε-caprolactone)/hydroxypropyl methylcellulose (HPMC) based composite electrospun membranes for tissue engineering applications79
Albumin-loaded thermo/pH dual-responsive nanogels based on sodium alginate and poly (N-vinyl caprolactam)54
Application of non-metal nanoparticles, as a novel approach, for improving the stability of blood products: 2011–202148
Fabrication of anti-bacterial cotton bandage using biologically synthesized nanoparticles for medical applications40
Mechanical performance and bioactivation of 3D-printed PEEK for high-performance implant manufacture: a review39
Effect of silicon or cerium doping on the anti-inflammatory activity of biphasic calcium phosphate scaffolds for bone regeneration35
Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies32
Characteristics of a decellularized human ovarian tissue created by combined protocols and its interaction with human endometrial mesenchymal cells31
Multi-antibacterial agent-based electrospun polycaprolactone for active wound dressing30
Promotion of nerve regeneration by biodegradable nanofibrous scaffold following sciatic nerve transection in rats29
Fabrication of porous TiO2 foams by powder metallurgy technique and study of bulk crushing strength for biomedical application27
In vitro DNA plasmid condensation and transfection through pH-responsive nanohydrogel26
Synthesis, physical properties, and biomedical applications of magnetic nanoparticles: a review23
Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery21
Correction to: Characteristics of a decellularized human ovarian tissue created by combined protocols and its interaction with human endometrial mesenchymal cells18
Differentiation of the mesenchymal stem cells to pancreatic β-like cells in alginate/trimethyl chitosan/alginate microcapsules16
Core–shell alum-borneol fiber for high bioavailability15
Correction to: Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery14
Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis14
0.079571008682251